Scripscan:Ajanta Pharma Ltd
Code:532331
cmp:100
Story:Ajanta Pharma Limited engages in the research, manufacture, and marketing of various pharmaceutical products principally in India.The company provides a range of therapeutic products covering segments, such as cardiology, dermatology, and ophthalmology, as well as anti retrovirals and anti malarials; and markets over-the-counter drugs. It offers pharmaceutical products in allopathic and herbal forms. The company’s allopathic products include anthelmintics, antibiotics, anti diarrhoeal, NSAIDs, analgesics, antyretics, anti histaminics, anti malarials, anti retrovirals, anti tussives/bronchodilator, anti tuberculosis, cardiovasculars, gastrointestinal, gynaecology and hormone, male erectile dysfunction, and nutraceutical/multivitamin products. Ajanta Pharma’s herbal products comprise aphrodisiac/energizers, digestive aids, metabolic correctives, and respiratory related products. The company offers its products in various forms, such as tablets, capsules, injections, ointments, and powders. It exports its products to 50 countries in Asia, Africa, Latin America, Europe, and the Commonwealth of Independent States.Its strong team of 2000 people comprises of a dedicated team of over 100 research scientists. The manufacturing plants comply with the highest regulatory guidelines.The company has been doing quite decent on the operatiional front.It enjoys a bood brand image,a regular dividend payer with management being neat and commited towards increasing the shareholder"s heaath.The same can be stem from the fact that it announced a buyback which gives tremendous confidence and conviction upon the outlook and future prospect of the company.At rs 100 its quoting a low single digit valuations its 1 year forward earnings.Looks worthbuying at present levels.
Search This Blog(Over 800 companies covered in the blog).
Please note
Archives : Old artciles
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
